Fuzeon and Ibrance drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Fuzeon (enfuvirtide) and Ibrance (palbociclib). Common drug interactions include leukopenia among males.
The phase IV clinical study analyzes what interactions people have when they take Fuzeon and Ibrance. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Fuzeon?
Fuzeon has active ingredients of enfuvirtide. eHealthMe is studying from 3,007 Fuzeon users. Check the latest studies of Fuzeon.
What is Ibrance?
Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.
12 people who take Fuzeon and Ibrance together, and have interactions are studied.
What are the common drug interactions of Fuzeon and Ibrance, by gender? *:
female:
n/a
male:
- Leukopenia (less number of white blood cells in blood)
- Lymphopenia (an abnormally low level of lymphocytes in the blood)
- Neutropenia (an abnormally low number of neutrophils)
What are the common drug interactions of Fuzeon and Ibrance, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Leukopenia (less number of white blood cells in blood)
- Lymphopenia (an abnormally low level of lymphocytes in the blood)
- Neutropenia (an abnormally low number of neutrophils)
60+:
n/a
What are the existing conditions these people have? *
- Pain: 12 people, 100.00%
- Hiv Test Positive: 12 people, 100.00%
- Dyslipidaemia (abnormal amount of lipids): 12 people, 100.00%
- Diabetes: 12 people, 100.00%
- Breast Cancer Male: 12 people, 100.00%
- Itching: 10 people, 83.33%
* Approximation only. Some reports may have incomplete information.
Do you take Fuzeon and Ibrance?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Fuzeon and Ibrance:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Fuzeon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ibrance:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fuzeon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ibrance and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on enfuvirtide and palbociclib (the active ingredients of Fuzeon and Ibrance, respectively), and Fuzeon and Ibrance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Joint Pain and Lymphoma - now
- Drug interactions of Copaxone and Vitamin B12 - 3 seconds ago
- Could Trelegy Ellipta cause Back Disorder? - 12 seconds ago
- Insomnia and Application Site Pruritus - 20 seconds ago
- Could Dexamethasone cause Hyperosmolar State? - 23 seconds ago
- Could Cyanocobalamin cause Tooth Fracture? - 25 seconds ago
- Could Buspar cause Alanine Aminotransferase Increased? - 27 seconds ago
- Could Azathioprine cause Euphoric Mood? - 30 seconds ago
- Could Ocrevus cause Nasal Discharge Discoloration? - 31 seconds ago
- Abscess and Confusional State - 34 seconds ago